A recent exome sequencing study has revealed that risk for Alzheimer's disease (AD) is partly explained by rare (minor allele frequency <1%) single nucleotide variants within ABI3, PLCG2, and TREM2, genes with known roles in microglia-mediated innate immunity [1]. This evidence concerns the gene PLCG2 and Alzheimer disease.